Notes
National Health Service
Reference
NICE. Skin cancer drug recommended for routine NHS use. Internet Document : 12 Feb 2021. Available from: URL: https://www.nice.org.uk/news/article/nivolumab-for-adjuvant-treatment-of-completely-resected-melanoma-with-lymph-node-involvement-or-metastatic-disease
Rights and permissions
About this article
Cite this article
NICE recommends nivolumab for melanoma in final draft guidance. PharmacoEcon Outcomes News 872, 34 (2021). https://doi.org/10.1007/s40274-021-7507-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7507-4